Terms: = Kidney tumors AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Prognosis
9 results:
1. Conditional Survival of Patients With Extracranial Oligometastatic Treated With Stereotactic Body Radiation Therapy: An International Consortium Study.
Chen H; Badellino S; Biswas T; Dagan R; Erler D; Foote M; Poon I; Redmond KJ; Ricardi U; Sahgal A; Louie AV
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):902-909. PubMed ID: 35753554
[TBL] [Abstract] [Full Text] [Related]
2. A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes.
Cao P; Wu JY; Zhang JD; Sun ZJ; Zheng X; Yu BZ; Cao HY; Zhang FL; Gao ZH; Wang W
BMC Cancer; 2022 Jun; 22(1):691. PubMed ID: 35739510
[TBL] [Abstract] [Full Text] [Related]
3. Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls.
Goebel S; Kehlen A; Bluemke K; Altermann W; Schlaf G; Fischer K; Fornara P; Wullich B; Wach S; Taubert H
Cancer Immunol Immunother; 2017 May; 66(5):565-571. PubMed ID: 28184970
[TBL] [Abstract] [Full Text] [Related]
4. Association Between HLA Type and Skin Cancer in kidney Transplant Recipients.
Cegielska A; Dębska-Ślizień A; Moszkowska G; Imko-Walczuk B; Rutkowski B
Transplant Proc; 2016 Jun; 48(5):1608-10. PubMed ID: 27496455
[TBL] [Abstract] [Full Text] [Related]
5. Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine prognosis in Clear Cell Renal Cell Carcinoma.
Matsushita H; Sato Y; Karasaki T; Nakagawa T; Kume H; Ogawa S; Homma Y; Kakimi K
Cancer Immunol Res; 2016 May; 4(5):463-71. PubMed ID: 26980598
[TBL] [Abstract] [Full Text] [Related]
6. The relationship between human leukocyte antigens (HLA) and renal cell carcinoma.
Yilmaz E; Çekmen A; Akkuş E; Önal B; Özalp AU; Solok V; Erdoğan E; Eren B
Bosn J Basic Med Sci; 2010 Nov; 10(4):282-6. PubMed ID: 21108609
[TBL] [Abstract] [Full Text] [Related]
7. Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study.
Westermann J; Flörcken A; Willimsky G; van Lessen A; Kopp J; Takvorian A; Jöhrens K; Lukowsky A; Schönemann C; Sawitzki B; Pohla H; Frank R; Dörken B; Schendel DJ; Blankenstein T; Pezzutto A
Gene Ther; 2011 Apr; 18(4):354-63. PubMed ID: 21068778
[TBL] [Abstract] [Full Text] [Related]
8. De novo renal carcinoma in renal transplant recipients: effect of early treatment.
Tillou X; Demailly M; Hakami F; Westeel PF; Saint F; Petit J
Transplant Proc; 2009 Oct; 41(8):3314-6. PubMed ID: 19857739
[TBL] [Abstract] [Full Text] [Related]
9. [IgA-immunoglobulins and hla-a1 antigen in Wilms' tumor. Significance for the prognosis of the disease].
Abrahámová J; Májský A; Fucíková T; Koutecký J
Onkologie; 1978 Oct; 1(5):177-9. PubMed ID: 215948
[TBL] [Abstract] [Full Text] [Related]
